Bellevue Group »

Newamsterdam Pharma Co Nv shares owned by Bellevue Group

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by Bellevue Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $128k 7.7k 16.60

More positions owned by Bellevue Group

Argenx Se Sponsored Adr (ARGX)
Ionis Pharmaceuticals (IONS)
Vertex Pharmaceuticals Incorporated (VRTX)
Intuitive Surgical Com New (ISRG)
Alnylam Pharmaceuticals (ALNY)
Revolution Medicines (RVMD)
Neurocrine Biosciences (NBIX)
Boston Scientific Corporation (BSX)
Abbott Laboratories (ABT)
Stryker Corporation (SYK)
Intra Cellular Therapies (ITCI)
Agios Pharmaceuticals (AGIO)
Incyte Corporation (INCY)
UnitedHealth (UNH)
Moderna (MRNA)

View all positions for Bellevue Group

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Fcpm Iii Services B.v.
Bain Capital Life Sciences Investors
RA Capital Management
Viking Global Investors
Medicxi Ventures Management
Cormorant Asset Management
BVF
Woodline Partners
Jennison Associates
Henderson Group
Pictet Asset Management Holding SA
Siren
Deerfield Management Company
Avidity Partners Management

View all funds holding Newamsterdam Pharma Co Nv